GoodRx sees FY24 revenue ~$794M, consensus $800.8M
PremiumThe FlyGoodRx sees FY24 revenue ~$794M, consensus $800.8M
3d ago
Notable companies reporting before tomorrow’s open
Premium
The Fly
Notable companies reporting before tomorrow’s open
3d ago
GoodRx announces exclusive cash price for Qsymia
Premium
The Fly
GoodRx announces exclusive cash price for Qsymia
11d ago
Charter names Simon Cassels as SVP, chief creative officer
PremiumThe FlyCharter names Simon Cassels as SVP, chief creative officer
3M ago
Raymond James upgrades GoodRx to Strong Buy after earnings selloff
Premium
The Fly
Raymond James upgrades GoodRx to Strong Buy after earnings selloff
3M ago
GoodRx upgraded to Strong Buy from Outperform at Raymond James
Premium
The Fly
GoodRx upgraded to Strong Buy from Outperform at Raymond James
3M ago
GoodRx Holdings Board Restructure and New Director Induction
PremiumCompany AnnouncementsGoodRx Holdings Board Restructure and New Director Induction
4M ago
GoodRx price target raised to $9.50 from $7 at Morgan Stanley
Premium
The Fly
GoodRx price target raised to $9.50 from $7 at Morgan Stanley
5M ago
GoodRx Board Revamp: Adam Karol Exits, Simon Patterson Joins
Premium
Company Announcements
GoodRx Board Revamp: Adam Karol Exits, Simon Patterson Joins
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100